Burden of Influenza at Emergency Department Level : BIED

Emergencies Clinical Trial

— BIED  

Official title:

Burden of Influenza at Emergency Department Level : BIED

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04153331
• Other study ID #: 69HCL19_0755
• Status: Completed
• Phase: N/A
• Start date: January 13, 2020
• Est. completion date: March 9, 2020

Study information

• Verified date: January 2020
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Seasonal influenza surveillance in France relies on several sources to detect the onset of the epidemic early, as well as to estimate the severity of epidemics and their impact on the health system. However, the data collected do not fully measure the impact of epidemics on the hospital system.

Increasing the investigator's knowledge of the impact of influenza on the hospital system, particularly on emergencies, which are the most affected service, is essential to better adapt the resources put in place to care for patients.

The study will allow a better understanding of the influenza burden, by systematically documenting the severe events (i.e. requiring consultations to the Emergency Rooms) that are triggered by influenza but not necessarily reported/recorded as influenza.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2487
• Est. completion date: March 9, 2020
• Est. primary completion date: March 9, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age > 18 years

• Consultation for a medical cause

Exclusion Criteria:

• Consultation for a non-medical cause (trauma...)

• Pregnant, parturient and lactating women

• Persons deprived of their liberty

• Persons of full age who are subject to a legal protection measure

• Persons not affiliated to a social security system

Related Conditions & MeSH terms

• Emergencies
• Flu

Intervention

Other:
• Nasal swab
Patient included in emergency with a nasal swab

Locations

Country	Name	City	State
France	Service Hygiène, Epidémiologie et Prévention	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of laboratory confirmed influenza among patients admitted to Emergency Room during the influenza season	The proportion of laboratory confirmed influenza cases will be calculated by dividing the number of patients with laboratory confirmed influenza by the total number of patients included	1 day (at admission)
Secondary	Proportion of patients with co-morbidities	to evaluate the proportion of patients consulting emergency department who have co-morbidities according to the result of the virological sampling	1 day (at admission)
Secondary	Proportion of patients with laboratory confirmed influenza and related outcomes	to estimate the proportion of patients with a laboratory confirmed influenza stratified on the emergency department visit outcomes (hospitalization in medicine, hospitalization in intensive care unit or return home) and other covariates	1 day (at admission)
Secondary	Proportion of patients who consult for other causes than influenza	to estimate the proportion of patients with a laboratory confirmed influenza consulting for other causes than influenza	1 day (at admission)
Secondary	Proportion of asymptomatic influenza cases among patients with laboratory confirmed influenza	The proportion asymptomatic influenza cases will be calculated by dividing the number of patients with asymptomatic influenza by the total number of laboratory confirmed influenza	1 day (at admission)